Capital Investment Advisory Services, LLC Intellia Therapeutics, Inc. Transaction History

Capital Investment Advisory Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$38.49 - $76.21 $134,753 - $266,811	-3,501 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$58.27 - $118.99 $31,116 - $63,540	-534 Reduced 13.23%	3,501 $254,000
Q4 2021 Feb 01, 2022	BUY	$100.76 - $138.36 $406,566 - $558,282	4,035 New	4,035 $477,000
Q3 2019 Oct 17, 2019	SELL	$13.07 - $18.51 $7,842 - $11,106	-600 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$13.88 - $18.41 $8,328 - $11,046	600 New	600 $11,000

319

91M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $799M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.